2026 ICD-10-CM Diagnosis Code D64.2Secondary sideroblastic anemia due to drugs and toxins

ICD-10-CM CodesD50–D89D60-D64D64

ICD-10-CM D64.2
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D64.2 is a billable ICD-10-CM diagnosis code for secondary sideroblastic anemia due to drugs and toxins. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 811 through 812. Coders also document this condition as alcohol-related sideroblastic anemia. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Aplastic anemia and Drug induced or toxic related condition.

D64.2 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 48 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the PACE (CMS-HCC V22) category 48, ESRD (V21) category 48, ESRD (V24) category 48, and RxHCC Part D (V08) category 96 for payment year 2026.

Code Identity

ICD-10-CM Code
D64.2
Billable Status
Yes — Valid for Submission
Code Describes
Secondary sideroblastic anemia due to drugs and toxins
Short Description
Secondary sideroblastic anemia due to drugs and toxins
Same as the full description in the CMS dataset.
Parent Code
Other anemias

Code Classification

ChapterD50–D89Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
SectionD60-D64Aplastic and other anemias and other bone marrow failure syndromes
CategoryD64Other anemias
This CodeD64.2Secondary sideroblastic anemia due to drugs and toxins

Medicare Risk Adjustment (HCC)Billing

D64.2 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.

CMS-HCC V28 (Medicare Advantage Payment Model)
Not mapped
Dropped in V28 see all codes that no longer risk-adjust
Prior Model (CMS-HCC V24)
HCC 48
V24 retired last contributed to a Medicare Advantage risk score in payment year 2025
Other CMS Models
PACE (CMS-HCC V22): HCC 48 · ESRD (V21): HCC 48 · ESRD (V24): HCC 48
ESRD V21 weights: 0.059 dialysis, 0.173–0.234 functioning graft · ESRD V24 weights: 0.063 dialysis, 0.192–0.358 functioning graft
Part D (RxHCC)
RxHCC 96 — Acquired Hemolytic, Aplastic, and Sideroblastic Anemias
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Alcohol-related sideroblastic anemia
  • Anemia caused by lead
  • Drug-induced sideroblastic anemia
  • Secondary acquired sideroblastic anemia

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Code First

  • poisoning due to drug or toxin, if applicable T36 T65

Use Additional Code

  • code for adverse effect, if applicable, to identify drug T36 T50

Index to Diseases and InjuriesGuidance

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR BLD003
Aplastic anemia
Default principal diagnosis: inpatient No · outpatient No
CCSR INJ030
Drug induced or toxic related condition
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Anemia

If you have anemia, your blood does not carry enough oxygen to the rest of your body. The most common cause of anemia is not having enough iron. Your body needs iron to make hemoglobin. Hemoglobin is an iron-rich protein that gives the red color to blood. It carries oxygen from the lungs to the rest of the body.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D64.2 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
285.0 Sideroblastic anemia
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D64.2Overview

What is the ICD-10 code for secondary sideroblastic anemia due to drugs and toxins?

The ICD-10-CM code for secondary sideroblastic anemia due to drugs and toxins is D64.2 (sometimes written as D642). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is D64.2 (Other anemias) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report secondary sideroblastic anemia due to drugs and toxins on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D64.2 group to?

When secondary sideroblastic anemia due to drugs and toxins is the principal diagnosis on an inpatient stay, it groups to MS-DRG 811, 812, with relative weights from 0.9182 to 1.4043 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D64.2?

Under the General Equivalence Mappings, secondary sideroblastic anemia due to drugs and toxins converts to ICD-9-CM 285.0 (sideroblastic anemia). The mapping is approximate, so confirm the match fits the documentation.

Does D64.2 risk-adjust for Medicare Advantage payment?

Not for Medicare Advantage. D64.2 mapped to HCC 48 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the PACE (CMS-HCC V22) category 48 (Coagulation Defects and Other Specified Hematological Disorders), ESRD (V21) category 48 (Coagulation Defects and Other Specified Hematological Disorders), ESRD (V24) category 48 (Coagulation Defects and Other Specified Hematological Disorders), and RxHCC Part D (V08) category 96 (Acquired Hemolytic, Aplastic, and Sideroblastic Anemias).